7-71415948-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_022479.3(GALNT17):c.649G>A(p.Val217Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 32)
Consequence
GALNT17
NM_022479.3 missense
NM_022479.3 missense
Scores
1
10
7
Clinical Significance
Conservation
PhyloP100: 7.38
Genes affected
GALNT17 (HGNC:16347): (polypeptide N-acetylgalactosaminyltransferase 17) This gene encodes an N-acetylgalactosaminyltransferase. This gene is located centromeric to the common deleted region in Williams-Beuren syndrome (WBS), a multisystem developmental disorder caused by the deletion of contiguous genes at 7q11.23. This protein may play a role in membrane trafficking. [provided by RefSeq, Jan 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GALNT17 | NM_022479.3 | c.649G>A | p.Val217Met | missense_variant | 4/11 | ENST00000333538.10 | NP_071924.1 | |
GALNT17 | XM_011516467.4 | c.649G>A | p.Val217Met | missense_variant | 4/10 | XP_011514769.1 | ||
GALNT17 | XM_017012521.3 | c.649G>A | p.Val217Met | missense_variant | 4/7 | XP_016868010.1 | ||
GALNT17 | XM_011516469.4 | c.649G>A | p.Val217Met | missense_variant | 4/6 | XP_011514771.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GALNT17 | ENST00000333538.10 | c.649G>A | p.Val217Met | missense_variant | 4/11 | 1 | NM_022479.3 | ENSP00000329654.5 | ||
GALNT17 | ENST00000467723.1 | n.583G>A | non_coding_transcript_exon_variant | 4/11 | 2 | |||||
GALNT17 | ENST00000498380.6 | n.1051G>A | non_coding_transcript_exon_variant | 4/11 | 2 | |||||
GALNT17 | ENST00000447516.5 | c.*17G>A | downstream_gene_variant | 4 | ENSP00000392019.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 30, 2022 | The c.649G>A (p.V217M) alteration is located in exon 4 (coding exon 4) of the WBSCR17 gene. This alteration results from a G to A substitution at nucleotide position 649, causing the valine (V) at amino acid position 217 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D
M_CAP
Benign
D
MetaRNN
Uncertain
D;D
MetaSVM
Uncertain
T
PrimateAI
Pathogenic
T
PROVEAN
Benign
N;.
REVEL
Benign
Sift
Benign
T;.
Sift4G
Uncertain
T;D
Polyphen
P;.
Vest4
MutPred
Loss of methylation at K216 (P = 0.0177);.;
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at